Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Latest news

10/12/2018 Database Update: Import of Veterinary Drugs, Feed, Feed Supplements and APIs to Russia (July 2018)

Between January and July 2018, Russia imported 36.5 bln RUB worth of veterinary products, which is in monetary terms 15.6% higher than that of the same period of 2017: 20.7 bln RUB of feed supplements (+17.3%), 14.6 bln RUB of veterinary drugs (+12.6%), and 1.2 bln RUB of veterinary APIs (+23.6%.)

10/11/2018 Database Update: API Import to Russia (July 2018)

Between January and July 2018, Russia imported 55 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms around 30% higher than that of the same period of 2018. The dynamics in physical terms are -2%, with 6.7 tons of APIs.

10/5/2018 Database Update: Pharmaceutical Drug Import to Russia (July 2018)

Between January and July 2018, Russia imported 291.3 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices), which is in monetary terms 3.2% higher than that of the same period of 2017. The dynamics of the import of in-bulk drugs are +28%, with 62.0 bln RUB. The dynamics of the total pharmaceutical drug import in monetary terms are +7%.

9/28/2018 RNC Pharma Database Update: Pharmaceutical Drug Production in Russia (August 2018)

Between January and August 2018, Russia produced 212.8 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms only 0.1% higher than that of the same period of 2017. In physical terms, Russia produced 2.61 bln units. The dynamics are -10.4%, which have been gradually decreasing for 10 months.

9/6/2018 Rating of Russian Pharmacy Chains (Q1-Q2 2018)

On the one hand, the first six months of 2018 for the Russian pharmaceutical retail was marked by a slight recovery in demand, which, despite failing to bring the segment out of the red zone, promised some growth by the end of the year, unless the macroeconomic situation changes.

All news [116]

Our competences

RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.